The NCS Investment Proposition 1. Leadership positions across a focused and Trading Statistics and differentiated portfolio of products and services Selected Financial Metrics* (In millions, except per share amounts) We enable our…
Fracturing Systems Pinpoint Stimulation Pinpoint Stimulation enables more predictable, repeatable and verifiable completions that maximize reservoir connectivity, as compared to other completion methods Other Completion Methods Pinpoint…
RATEK Frac Sleeves Key Features and Use Cases Frac Sleeves V0 (gas-tight) qualified MultiCycleTM First installation in December 2021 in frac sleeves for use in demanding the North Sea applications, including: High Collapse High…
Repeat Precision Joint Venture PurpleSeal composite frac plug family of products 4.5, 5.5 and 6.0 specifications All composite, hybrid and dual-cast frac plug designs and hybrid bridge plug PurpleSeal ExpressTM disposable frac plug…
Tracer Diagnostics Leading provider of chemical and radioactive tracers for well diagnostics and reservoir characterization Cost-effective and reliable service utilized by E&P companies to optimize completion designs and field…
How Customers Utilize Tracers Common Tracer Uses FirstView 3D interactive animation Evaluate well spacing and diagnose frac hits Fast, economical completion design optimization Verify stage contributions Calculate cluster…
Secondary Recovery and EOR Solutions Solutions to facilitate secondary recovery and EOR in multistage horizontal wells Secondary recovery and EOR can help customers reduce corporate decline rates and maximize resource recovery…
Well Construction Single-source provider of well construction solutions Proprietary technologies to support casing and liner installation and for initial formation access AirLock casing buoyancy system VectrasetTM liner hanger…
Expanded Addressable Market NCS has expanded its addressable market and diversified its business through organic sales and new product development, the Repeat Precision joint venture and the Spectrum acquisition 2016 - 98 mm Revenue…
Growth and Financial Execution
Q1 2022 Financial Results Q1 2022 Performance: Total revenue of 39.1 million, an 8% sequential increase and a 37% increase compared to Q1 2021 U.S. revenue of 9.1 million; Canadian revenue of 28.5 million; International revenue of 1.5…
Q2 2022 and 2022 Full Year Financial Guidance Q2 2022 Financial Guidance*: Total Revenue of 26.0 - 29.0 million Cost of sales, excluding depreciation and amortization, of 60% - 65% of revenue S,G&A of 14.5 - 15.5 million, including…
Revenue Profile Revenue Contribution Twelve Months Ended March 31, 2022 By Geography Product and Service Mix 17
Evolving Geographic Mix U.S. and International markets represented 37% of total revenue during the twelve months ended March 31, 2022 as compared to under 30% in 2016 2016 Revenue - 98 mm LTM Revenue March 31, 2022 - 129 mm 6% 9%…
High Margins with Free Cash Flow Financial and operating model minimizes capital investment and maximizes free cash flow Revenue (millions) Gross Profit (millions) and % Margin Adjusted EBITDA (millions) and % Margin* Free Cash Flow…
The NCS Investment Proposition 1. Leadership positions across a focused and Trading Statistics and differentiated portfolio of products and services Selected Financial Metrics* (In millions, except per share amounts) We enable our…
Appendix
Everything Starts with The Promise We will invest in our employees, our most important resource, by providing coaching and training that enables them to learn and grow to their full potential. Together, we will maintain a culture that…
Adjusted EBITDA Reconciliation Year Ended December 31, Three Months Ended March 31, ( in millions) 2017 2018 2019 2020 2021 2021 2022 Net Income (Loss) 1.3 (185.2) (22.8) (39.1) (3.8) (3.5) (1.7) Income Tax Expense (Benefit) 0.7 (23.1)…
Free Cash Flow and Net Working Capital Reconciliations Free Cash Flow Year Ended December 31, Three Months Ended March 31, ( in millions) 2017 2018 2019 2020 2021 2021 2022 Net Cash Provided by Operating Activities 16.1 14.0 17.9 35.1…
Loading...
